<p>143B cells were transfected with Lipofectamine only or siRNAs against the control VP16 or the positive hits Arf1, DDX3X and eIF4H. They were then infected at a MOI of 5 with HSV-1 K26GFP and the supernatants collected at 24 hours. Concentrated supernatants corresponding to equal amounts of VP5 were analyzed and 20 µg of Lipofectamine-treated cell lysates were used as control. The reduced levels of <b>A</b>) VP16, <b>B</b>) ARF1, <b>C</b>) DDX3X and <b>D</b>) eIF4H in newly produced virions in the supernatants were confirmed by Western blotting.</p
To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.